This federal Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $49,000,000 single-award IDC has a period of performance through January 29, 2029.
Under this IDC, Cepheid is providing the DLA Troop Support Medical and other participating federal agencies with a variety of molecular diagnostic equipment, reagents, consumables, and associated maintenance and support services. Cepheid's products, such as its GeneXpert diagnostic systems and compatible test kits, are used to detect infectious diseases including COVID-19, influenza, respiratory syncytial virus, sexually transmitted infections, and more. The contract supports clinical testing programs across the Department of Defense, Department of Veterans Affairs, and other federal healthcare facilities. While this IDC does not have a set-aside designation, Cepheid holds several other federal Indefinite Delivery/Indefinite Quantity (IDIQ) contracts, including with the VA, to continuously supply its molecular diagnostic solutions.
Generated 8/22/24, 2:58 PM